Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA

BACKGROUND: Blood-based methods using cell-free DNA (cfDNA) are under development as an alternative to existing screening tests. However, early-stage detection of cancer using tumor-derived cfDNA has proven challenging because of the small proportion of cfDNA derived from tumor tissue in early-stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Nathan, Weinberg, David, Liu, Tzu-Yu, Niehaus, Katherine, Ariazi, Eric A., Delubac, Daniel, Kannan, Ajay, White, Brandon, Bailey, Mitch, Bertin, Marvin, Boley, Nathan, Bowen, Derek, Cregg, James, Drake, Adam M., Ennis, Riley, Fransen, Signe, Gafni, Erik, Hansen, Loren, Liu, Yaping, Otte, Gabriel L., Pecson, Jennifer, Rice, Brandon, Sanderson, Gabriel E., Sharma, Aarushi, St. John, John, Tang, Catherina, Tzou, Abraham, Young, Leilani, Putcha, Girish, Haque, Imran S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708173/
https://www.ncbi.nlm.nih.gov/pubmed/31443703
http://dx.doi.org/10.1186/s12885-019-6003-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708173/
https://www.ncbi.nlm.nih.gov/pubmed/31443703
http://dx.doi.org/10.1186/s12885-019-6003-8

Ejemplares similares